(19)
(11) EP 1 581 184 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.09.2013 Bulletin 2013/36

(45) Mention of the grant of the patent:
24.08.2011 Bulletin 2011/34

(21) Application number: 03775738.2

(22) Date of filing: 08.12.2003
(51) International Patent Classification (IPC): 
A61K 9/06(2006.01)
A61P 31/04(2006.01)
 A61K 9/10(2006.01)
(86) International application number:
PCT/IB2003/005825
(87) International publication number:
WO 2005/051352 (09.06.2005 Gazette 2005/23)

(54)

VETERINARY COMPOSITIONS FOR TREATING MASTITIS

ZUSAMMENSETZUNGEN ZUR TIERÄRZTLICHEN BEHANDLUNG VON MASTITIS

COMPOSITIONS VÉTÉRINAIRES DESTINÉES AU TRAITEMENT DE LA MAMMITE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30) Priority: 20.12.2002 GB 0229642

(43) Date of publication of application:
05.10.2005 Bulletin 2005/40

(73) Proprietors:
  • Zoetis UK Limited
    London EC4A 3AE (GB)
    Designated Contracting States:
    GB 
  • Zoetis LLC
    Florham Park NJ 07932 (US)
    Designated Contracting States:
    AT BE BG CH CY CZ DE DK EE ES FI FR GR HU IE IT LI LU MC NL PT RO SE SI SK TR 

(72) Inventor:
  • DORGAN, Roderick John Jeremiah, Pfizer Global R&D
    Kent, CT13 9NJ (GB)

(74) Representative: Mannion, Sally Kim et al
Zoetis UK Limited Walton Oaks Dorking Road
Tadworth Surrey KT20 7NS
Tadworth Surrey KT20 7NS (GB)


(56) References cited: : 
EP-A- 0 271 306
GB-A- 2 273 441
 GB-A- 1 456 349
US-B1- 6 254 881
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).